Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

BioNTech
Biotech
Amgen
Gilead Sciences
Topics

Advertisement

Advertisement

BioNTech

Share

Top Latest Popular

Yesterday

Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success? The Motley Fool 22:42 Tue, 22 Sep

BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline? The Motley Fool 10:00 Tue, 22 Sep

Friday

BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried? The Motley Fool 10:00 Fri, 18 Sep

Advertisement

Advertisement

In the last month

WCLC 2026: BioNTech’s Gotistobart Looks Closer To Big Win In NSCLC Scrip Pharma Intelligence 18:05 Tue, 15 Sep

New lung cancer drug lifts survival versus chemotherapy Los Angeles Times 15:13 Tue, 15 Sep

BioNTech says lung cancer drug candidate nearly doubles survival Daily Sabah 13:13 Tue, 15 Sep

BioNTech and OncoC4 report median OS data from RESERVE-003 Phase III trial Clinical Trials Arena 11:04 Tue, 15 Sep

WCLC: Lung cancer news from BioNTech, Akeso, and Roche pharmaphorum 10:28 Tue, 15 Sep

Why Is BioNTech Stock Gaining Monday? Benzinga 15:41 Mon, 14 Sep

BioNTech's Gotistobart Nearly Doubles Median Overall Survival In Previously Treated Squamous Nsclc RTT News 12:38 Mon, 14 Sep

Protecting Intellectual Property Rights Will Save Lives Now and in the Future The Independent Institute (Weblog) 08:31 Wed, 09 Sep

How Trial Termination At BioNTech (BNTX) Has Changed Its Investment Story Simply Wall St 21:26 Tue, 08 Sep

Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine approved by US FDA PMLiVE 11:15 Fri, 04 Sep

BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now? The Motley Fool 22:40 Thu, 03 Sep

Is BioNTech Stock a No-Brainer Buy on the Dip? The Motley Fool 20:32 Wed, 02 Sep

BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible? Simply Wall St 13:20 Wed, 02 Sep

BioNTech Halted a Cancer Vaccine Trial, and Genentech Says There Were More Deaths in the Vaccine Group Medical Daily 02:00 Tue, 01 Sep

FDA approves updated COVID vaccines targeting XFG ‘Stratus’ variant FOX13 Seattle 22:24 Fri, 28 Aug

Advertisement

BioNTech Terminates Phase 2 Trial Of Autogene Cevumeran In Colorectal Cancer RTT News 16:37 Fri, 28 Aug

BioNTech Stock Dips After BNT122-01 Trial Termination Benzinga 16:19 Fri, 28 Aug

FDA approves updated COVID vaccines for 2026-27 season Just The News 16:12 Fri, 28 Aug

FDA Approves Updated Covid Vaccines NewsMax 13:10 Fri, 28 Aug

FDA approves latest version of Pfizer's Covid-19 mRNA vaccine UPI 00:30 Fri, 28 Aug

Pfizer and BioNTech Receive U.S. FDA Approval for Xfg-adapted Covid-19 Vaccine Business Wire (Press Release) 21:30 Thu, 27 Aug

BreakBio, the Third Player in Personalized Drugs, Enters the Clinic PR Newswire (Press Release) 22:44 Mon, 24 Aug

BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing Barchart 15:20 Mon, 24 Aug

BioNTech (BNTX) Is Up 27.3% After Novel Pumitamig Combo Data in Lung Cancer – Has The Bull Case Changed? Simply Wall St 14:26 Mon, 24 Aug

Advertisement

Advertisement

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna